These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 31729720)
41. [Management of feto-maternal red cell allo-immunizations]. Bricca P; Guinchard E; Guitton Bliem C Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546 [TBL] [Abstract][Full Text] [Related]
42. Hemolytic disease of the newborn caused by irregular blood subgroup (Kell, C, c, E, and e) incompatibilities: report of 106 cases at a tertiary-care centre. Karagol BS; Zenciroglu A; Okumus N; Karadag N; Dursun A; Hakan N Am J Perinatol; 2012 Jun; 29(6):449-54. PubMed ID: 22399212 [TBL] [Abstract][Full Text] [Related]
44. Neonatal BO Incompatibility Is Associated With a Positive Cord Blood Direct Antiglobulin Test in Infants of Black Ethnicity. Özgönenel B; Kukreja G; O'Malley B; Bluth MH J Pediatr Hematol Oncol; 2015 Nov; 37(8):e453-7. PubMed ID: 26422285 [TBL] [Abstract][Full Text] [Related]
45. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]. Li ZH; Wang J; Chen C Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522 [TBL] [Abstract][Full Text] [Related]
46. A laboratory survey of A-B-O blood-group incompatibility and neonatal jaundice. Brink S S Afr Med J; 1969 Aug; 43(34):1047-50. PubMed ID: 5387801 [No Abstract] [Full Text] [Related]
47. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility. Weng YH; Chiu YW Chang Gung Med J; 2009; 32(4):400-8. PubMed ID: 19664346 [TBL] [Abstract][Full Text] [Related]
48. [Clinical analysis of seven cases of rare hemolytic disease of the newborn]. Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824 [No Abstract] [Full Text] [Related]
50. Severe Hemolytic Disease of a Newborn with Bilirubin of 37.3 mg/dL and High anti-A Titer: Corrected with Reconstituted Whole Blood Exchange. Ye Z; Wadsworth M; Wolf L; Jones S; Cotten K; Dasgupta A Ann Clin Lab Sci; 2024 May; 54(3):413-415. PubMed ID: 39048171 [TBL] [Abstract][Full Text] [Related]
51. Neonatal hemolytic disease: How should we use indirect and direct antiglobulin tests? Sevuk Ozumut SH; Turhan AB Pediatr Neonatol; 2024 Jan; 65(1):11-16. PubMed ID: 37414722 [TBL] [Abstract][Full Text] [Related]
52. Significance of immunohematologic testing in mother and newborn ABO incompatibility. Novoselac J; Buzina Marić K; Rimac V; Selak I; Raos M; Golubić Ćepulić B Immunohematology; 2023 Jun; 39(2):55-60. PubMed ID: 37405847 [TBL] [Abstract][Full Text] [Related]
53. [On the problem of ABO-incompatibility]. Rudelić I Med Klin; 1967 Nov; 62(47):1825-7. PubMed ID: 5588927 [No Abstract] [Full Text] [Related]
54. Combination of ABO blood group incompatibility and glucose-6-phosphate dehydrogenase deficiency: effect on hemolysis and neonatal hyperbilirubinemia. Kaplan M; Vreman HJ; Hammerman C; Leiter C; Rudensky B; MacDonald MG; Stevenson DK Acta Paediatr; 1998 Apr; 87(4):455-7. PubMed ID: 9628306 [TBL] [Abstract][Full Text] [Related]